FDA Inspection 1135805 - Aliri USA Inc. - January 14, 2021

FDA Inspection 1135805 for Aliri USA Inc. on January 14, 2021. Classification: No Action Indicated (NAI).

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 1135805 for Aliri USA Inc. on January 14, 2021. Classification: No Action Indicated (NAI).

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Aliri USA Inc.

Inspection Date

January 14, 2021

Product Type

Drugs

Office

Center for Drug Evaluation and Research

ID: 157a503e-08a7-4e24-aff7-cb42b233cc4f

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox